Table 1.
Clinical information on transplant patients.
| Patient ID | Type of transplant | Specimen | HCMV D/R serostatus | Time span from first to last sample (days) | Number of sequential samples | Antiviral regime |
|---|---|---|---|---|---|---|
| SYD-1 | Allogeneic hematopoietic stem cell | Plasma | D+/R+ | 336 | 6 | GCV, HCMV-T |
| SYD-2 | Allogeneic hematopoietic stem cell | Plasma | D+/R+ | 175 | 10 | FSC, GCV, CDV |
| GLA-1 | Renal | Plasma | D+/R– | 31 | 5 | GCV, vGCV |
| GLA-2 | Renal | Plasma | D–/R– | 16 | 4 | GCV, vGCV |
| GLA-3 | Renal | Plasma | NA/R– | 31 | 9 | GCV, vGCV |
| GLA-4 | Cardiac | Plasma | D+/R– | 30 | 8 | GCV, vGCV |
| HAN-1 | Renal | Blood | D+/R– | 179 | 4 | GCV, vGCV |
| HAN-2 | Renal | Blood | D–/R+ | 135 | 2 | GCV, vGCV |
| HAN-3 | Renal | Blood | D+/R+ | 207 | 2 | vGCV |
| HAN-4 | Renal | Blood | D+/R– | 123 | 5 | vGCV |
| HAN-5 | Renal/Pancreatic | Blood | D+/R– | 87 | 7 | FSC, vGCV |
D, donor; R, recipient; HCMV-T, HCMV-specific T cells; CDV, cidofovir; GCV, ganciclovir; vGCV, valganciclovir; FSC, foscarnet; NA, data not available.